Patrocinado
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Postado
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia mais
Jadeja makes history: Breaks Sobers’ 59-yr-old record, overtakes Kohli & Gavaskar
Ravindra Jadeja etched his name in cricket history during the fifth Test against England,...
Shubman Gill, KL Rahul, Ravindra Jadeja create historic feat in England
In a historic moment for Indian Test cricket, Shubman Gill, KL Rahul, and Ravindra Jadeja have...
Trump’s tariff reset: From Canada to Laos, even dealmakers face higher costs as legal fight brews; US allies & rivals hit with steep import taxes under new trade rules
Donald Trump's new tariff policy is creating economic problems worldwide. Countries face high...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese (Brazil)
